Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
about
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchInfluence of apolipoprotein A-V on the metabolic fate of triacylglycerolAPOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley ratsStructural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycansThe role of apolipoprotein A5 in obesity and the metabolic syndrome.Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS.
P2860
Q26746279-1591A0D8-A5FE-41FE-8C33-2BD04E238085Q26775009-6483B31F-048C-4321-96B9-A15F40D4FAB4Q28256394-0E90F285-2B2E-424A-AF55-ECCA926D887DQ28275573-AEF81B69-C79C-4BB4-A5A6-92E89258B5C3Q28281468-FBA93197-E353-4F1A-9A63-0C5BF5EE4F68Q34476810-6C2066C9-E7BE-4F96-A585-E0C78270A4E7Q35592272-D7DA389E-1582-4CA6-B9E9-C89042987071Q36345922-D4D9F4DB-C10C-44EA-BB8A-736BE131D715Q36744086-FD87B2AF-F736-4860-B8D7-8924D942D7C2Q36856055-0A615AA6-9350-472D-A4B7-20FB3DAE916CQ36891073-FC34B7F8-1D3F-4C2D-AD63-F647EBAB3CB6Q38070859-7763FC3E-D878-47EB-B3D4-9E282CB3B1FAQ39303512-E6D0B271-F3CE-4340-8C45-732D02FDE15DQ39896235-F007B716-208C-4204-90B5-E0B063CCF8AF
P2860
Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@ast
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@en
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@nl
type
label
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@ast
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@en
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@nl
prefLabel
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@ast
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@en
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@nl
P2093
P2860
P1476
Intravenous injection of apoli ...... lipoprotein-binding protein 1.
@en
P2093
Braydon L Burgess
Jennifer A Beckstead
Lisa Nelbach
Michael M Weinstein
Stephen G Young
Trudy M Forte
P2860
P304
P356
10.1161/ATVBAHA.110.210815
P407
P577
2010-10-21T00:00:00Z